IRIS
CANTARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.106
EU - Europa 29.061
AS - Asia 17.729
SA - Sud America 3.501
AF - Africa 1.176
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 21
AN - Antartide 1
Totale 86.669
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.624
GB - Regno Unito 7.335
RU - Federazione Russa 5.935
SG - Singapore 5.722
CN - Cina 5.392
IT - Italia 4.387
IE - Irlanda 2.967
BR - Brasile 2.905
VN - Vietnam 2.001
UA - Ucraina 1.666
HK - Hong Kong 1.564
FR - Francia 1.553
DE - Germania 1.549
SE - Svezia 1.423
FI - Finlandia 1.064
KR - Corea 984
ZA - Sudafrica 676
IN - India 518
NL - Olanda 294
CA - Canada 236
AR - Argentina 209
TR - Turchia 207
BD - Bangladesh 203
IQ - Iraq 190
PL - Polonia 186
JP - Giappone 178
MX - Messico 147
ES - Italia 140
PK - Pakistan 109
CI - Costa d'Avorio 104
EC - Ecuador 97
ID - Indonesia 95
AT - Austria 88
NG - Nigeria 83
CZ - Repubblica Ceca 78
KE - Kenya 78
VE - Venezuela 73
BE - Belgio 71
AU - Australia 66
UZ - Uzbekistan 65
CL - Cile 59
MA - Marocco 59
SA - Arabia Saudita 59
CH - Svizzera 57
CO - Colombia 53
IR - Iran 46
EG - Egitto 41
AE - Emirati Arabi Uniti 40
DZ - Algeria 37
MY - Malesia 35
NP - Nepal 35
JO - Giordania 34
PH - Filippine 34
LT - Lituania 33
PE - Perù 33
PY - Paraguay 28
TN - Tunisia 27
IL - Israele 26
KZ - Kazakistan 26
UY - Uruguay 24
GR - Grecia 22
DK - Danimarca 21
RO - Romania 21
BG - Bulgaria 20
BY - Bielorussia 20
LB - Libano 20
JM - Giamaica 18
AL - Albania 17
ET - Etiopia 16
EU - Europa 16
HU - Ungheria 16
PT - Portogallo 16
AZ - Azerbaigian 15
CR - Costa Rica 15
PA - Panama 15
BO - Bolivia 14
SN - Senegal 14
EE - Estonia 13
OM - Oman 13
LV - Lettonia 12
TW - Taiwan 11
BH - Bahrain 10
DO - Repubblica Dominicana 10
KG - Kirghizistan 10
PS - Palestinian Territory 10
TH - Thailandia 10
CY - Cipro 9
AM - Armenia 8
RS - Serbia 8
BB - Barbados 7
GE - Georgia 7
HN - Honduras 7
HR - Croazia 7
LY - Libia 7
MK - Macedonia 7
NO - Norvegia 7
QA - Qatar 7
SV - El Salvador 7
AO - Angola 6
BA - Bosnia-Erzegovina 6
Totale 86.543
Salva come PNG Salva come JPEG
Città #
Southend 6.689
Dallas 5.898
Singapore 3.509
Fairfield 3.336
Dublin 2.923
Ashburn 2.487
Santa Clara 1.712
Chandler 1.703
Moscow 1.632
Woodbridge 1.580
Hong Kong 1.477
Wilmington 1.355
Houston 1.339
Jacksonville 1.320
Hefei 1.294
Seattle 1.264
Beijing 1.150
Cambridge 1.124
San Jose 1.039
Seoul 970
Siena 859
Ann Arbor 840
The Dalles 673
Menlo Park 655
Helsinki 628
Johannesburg 619
Ho Chi Minh City 593
Los Angeles 592
Princeton 536
Milan 520
Lauterbourg 508
Hanoi 485
Council Bluffs 482
New York 472
Munich 459
Nanjing 454
São Paulo 268
Rome 259
Boardman 258
Buffalo 246
San Mateo 232
Florence 220
San Diego 202
Bengaluru 176
Düsseldorf 172
Dong Ket 161
Columbus 152
Orem 151
Nanchang 141
Redondo Beach 136
Frankfurt am Main 135
London 135
Chicago 132
Shenyang 126
Warsaw 120
Shanghai 111
Tokyo 109
Abidjan 104
Dearborn 100
Turku 100
Rio de Janeiro 94
Nuremberg 92
Lappeenranta 89
Da Nang 83
Tianjin 83
Changsha 82
Chennai 82
Haiphong 82
Abuja 80
Guangzhou 76
Montreal 76
Toronto 76
Washington 74
Brooklyn 70
Hebei 68
Baghdad 67
Jiaxing 67
San Francisco 66
Belo Horizonte 64
Denver 61
Stockholm 61
Jinan 60
Brussels 57
Amsterdam 56
Izmir 56
Tashkent 55
Atlanta 52
Kunming 51
Portsmouth 51
Venezia 51
Manchester 50
Norwalk 50
Bologna 49
Boston 48
Mexico City 46
Málaga 46
Zhengzhou 46
Naples 45
Olomouc 45
Brasília 44
Totale 59.673
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 863
A first update on mapping the human genetic architecture of COVID-19 575
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 574
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 506
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 499
Genetic mechanisms of critical illness in COVID-19 410
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 400
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 387
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS) 367
An explainable model of host genetic interactions linked to COVID-19 severity 365
Antirheumatic agents in covid-19: is IL-6 the right target? 354
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 350
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 348
Antiangiogenic VEGF isoform in inflammatory myopathies 346
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 344
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 342
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 337
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 329
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 326
Pathogen-sugar interactions revealed by universal saturation transfer analysis 323
null 320
Peripheral biomarkers' panel for severe COVID-19 patients 316
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 313
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 312
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 311
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 311
A case of amyloid myopathy in a patient with familial Mediterranean fever 310
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 309
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 308
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 308
Colchicine myopathy and neuromyopathy: two cases with different characteristics 295
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry 293
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 292
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 291
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 291
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 288
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 286
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 283
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 283
Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups 282
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 280
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 280
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 273
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 272
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 270
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 269
Eosinophils in inflammatory muscle disorders: a morphologic and immunohistological study. 268
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 267
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 266
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 262
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 262
The 2014 ACR annual meeting: a bird's eye view of autoimmunity in 2015 259
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 258
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 256
Clodronate in the management of different musculoskeletal conditions 254
A national cohort study on pediatric Behçet's disease: Cross-sectional data from an Italian registry 253
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 253
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 252
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 251
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 248
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 245
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 244
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria 243
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 242
Autoinflammatory disorders and patients with isolated serosal involvement. 241
Weekly oral alendronate in mevalonate kinase deficiency 239
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 238
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 237
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 236
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 235
Therapeutic effect of spa therapy and short wave therapy in knee osteoarthritis: a randomized, single blind, controlled trial 235
Recommendations for the management of autoinflammatory diseases 235
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 235
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 235
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 235
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders 234
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 233
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 233
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 232
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 230
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 230
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes 229
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 229
Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure 229
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 225
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 224
Biological treatments in Behçet's disease: beyond anti-TNF therapy 222
Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease 222
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 222
Clinical and biochemical landmarks in systemic autoinflammatory diseases 221
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 220
Untangling the Web of Systemic Autoinflammatory Diseases 220
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 217
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice 217
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 216
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations 216
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined 215
Immunometabolic biomarkers of inflammation in Behçet's disease: Relationship with epidemiological profile, disease activity and therapeutic regimes 215
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 215
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 215
Totale 28.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 251.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 251.903
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.673 0 0 0 0 0 0 0 0 0 587 454 632
2021/20225.082 494 567 335 334 286 183 227 204 365 627 508 952
2022/20236.237 407 417 733 884 616 1.259 238 501 650 135 244 153
2023/20245.263 236 162 480 278 229 1.332 1.531 206 43 161 163 442
2024/202514.742 600 710 1.543 802 1.633 826 654 832 1.018 708 1.488 3.928
2025/202632.056 2.531 5.405 4.522 4.072 5.882 1.536 3.751 1.365 1.309 1.683 0 0
Totale 88.314